Strategic leadership Leverage Abzena’s recognized leadership in Innovation and Growth in the ADC CDMO market to approach potential biotech partners seeking best-in-class development and manufacturing capabilities.

End-to-end capabilities Highlight Abzena’s integrated CDMO+CRO model from discovery to commercial launch to prospective clients needing streamlined, de-risked programs and single-source project management.

Strategic partnerships Target companies with discovery to late-stage needs by emphasizing recent collaborations (Mabqi integration) and leadership hiring (CEO, CBO) to signal scale, investment, and expanded capabilities.

Technical differentiation Promote Abzena’s technical expansions, such as GS knockout CLD platforms and ADCC+ afucosylation capabilities, to differentiate from peers for next-generation cell line development and complex biologics.

Geographic reach Position Abzena’s global footprint (San Diego, Bristol, Cambridge) as a advantage for multinational programs, enabling localized support, faster timelines, and regulatory alignment across regions.